Data Bridge Market Research

Dry Eye Syndrome Treatment Market 2017: Global Industry Research and Current Scenario 2024

Dry Eye Syndrome Treatment Market , By products {Nutritional Supplements, Serum Eye Drops, Lubricant Eye Drops (Oily Tear Eye Drops, Ointments, Preservative Free Eye Drops), Anti inflammatory Drugs, Autologous Serum Eye Drops}, Distribution channels (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies); End User (Clinics, Hospitals ); Geography (North America, Europe, Asia-Pacific, South America, Middle East, Africa).Global Industry Demand, Trends, Growth and Analysis 2024


Pune, India -- (SBWIRE) -- 01/31/2018 -- The Global Dry Eye Syndrome Treatment Market accounted for USD 3.42 billion in 2016 growing at a CAGR of 6.9% during the forecast period of 2017 to 2024. The upcoming market reports contain data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Market Definition: Global Dry Eye Syndrome Treatment Market

Dry eye syndrome treatment is required when tears are not able to provide adequate moisture in eyes. The market provides numerous treatment methods in the form of surgeries, eye drops, nutrition and many more.

Get Sample PDF Brochure @       

Global Dry Eye Syndrome Treatment Market : Major market drivers and restraints:

- Growing prevalence of dry eye syndrome among geriatric population

- Increasing number of life style diseases

- Rising geriatric population

- Growing awareness about the syndrome and rising demand for the treatment

- Increasing research and development activities

- Involvement of government health authorities

- Self-medication by patients

Global Dry Eye Syndrome Treatment Market Segmentation:

On the basis of products, the market for dry eye syndrome treatment is segmented into nutritional supplements, serum eye drops, lubricant eye drops, anti inflammatory drugs, and surgeries. The lubricant eye drops are further sub-segmented into oily tear eye drops ointments, and preservative free eye drops.

On the basis of distribution channels the  global dry eye syndrome treatment market is segmented into hospital pharmacies, eye health clinics, retail pharmacies, online pharmacies. Among which retail pharmacies dominates the overall market. .

On the basis of end users, the global dry eye syndrome treatment market is segmented into clinics and hospitals.

On the basis of geography, dry eye syndrome treatment report covers data points for 28 countries across multiple geographies such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

North America and Europe will collectively dominate the market throughout the forecast period; however, the individual revenue share will incur a marginal decline towards the latter half of the forecast period. Due to rising pollution levels and proximity of industrial contamination, the demand for dry eye syndrome treatment will significantly increase in Asia-Pacific.           

Have Any Query? Ask Ours Expert @                       

Global Dry Eye Syndrome Treatment Market – Competitive Analysis:

The dry eye syndrome treatment market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of dry eye syndrome treatment market for global, Europe, North America, Asia Pacific, and South America.

Global Dry Eye Syndrome Treatment Market – Major Market Competitors:

Global dry eye syndrome treatment market is dominated by Novartis AG, ALLERGAN, Alcon (a subsidiary of Novartis AG), Santen Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd, Nicox, ArGentis, Auven Therapeutics, Bridge Pharma Inc., Cellzome GmbH (a subsidiary of GlaxoSmithkline Group), Scope Ophthalmics Ltd., Reckitt Benckiser Group plc., Medicom Healthcare, FDC, Lupin Pharmaceuticals, Inc. , Jamjoom Pharmaceuticals Co., among others.

Know More About our Knowledge Store @